Community-based therapeutic drug monitoring. Useful development or unnecessary distraction?

Central pseudorapidity gaps in events with a leading antiproton at the fermilab tevatron pp collider.

Physical review letters·2003

Search for associated production of Upsilon and vector boson in pp collisions at sqrt[s]=1.8 TeV.

Physical review letters·2003

Search for the supersymmetric partner of the top quark in dilepton events from pp collisions at square root of s=1.8 TeV.

Physical review letters·2003

Search for long-lived charged massive particles in pp collisions at square root s = 1.8 TeV.

Physical review letters·2003

Comparison of modular and non-modular xylanases as carrier proteins for the efficient secretion of heterologous proteins from Penicillium funiculosum.

Applied microbiology and biotechnology·2003

Search for a W' boson decaying to a top and bottom quark pair in 1.8 TeV pp collisions.

Physical review letters·2003

Clinical Pharmacokinetics and Disposition of Imrecoxib.

Clinical pharmacokinetics·2026

Towards Model-Informed Precision Dosing of High-Dose Rifampicin: A Parsimonious Population Pharmacokinetic Model Capturing Saturation and Autoinduction in Tanzanian and South African Patients with Tuberculosis.

Clinical pharmacokinetics·2026

From Clinical Trials to Real-World Patients: Population Pharmacokinetics and Precision Dosing Simulations of Lorlatinib.

Clinical pharmacokinetics·2026

Clinical Pharmacokinetics and Pharmacodynamics of Marstacimab, an Anti-tissue Factor Pathway Inhibitor Monoclonal Antibody, in Adolescent and Adult Participants with Hemophilia.

Clinical pharmacokinetics·2026

Target Attainment and Clinical and Biochemical Parameters Associated with the Pharmacokinetics of 12 Tyrosine Kinase Inhibitors.

Clinical pharmacokinetics·2026

A First-in-Human Study of Ulacamten, a Novel Cardiac Myosin Inhibitor for HFpEF.

Clinical pharmacokinetics·2026

Chelidonium majus L. alkaloid extract encapsulated in human serum albumin nanoparticles induces mitochondria-mediated apoptosis in HeLa cell line.

Cellular and molecular biology (Noisy-le-Grand, France)·2026

Reduced severe infection risk with avacopan in ANCA-associated vasculitis: a multicentre REVEAL cohort with time-varying exposure modelling.

Rheumatology (Oxford, England)·2026

RETRACTED: D'Agostino et al. Molecular Mechanisms at the Basis of Pharmaceutical Grade Triticum vulgare Extract Efficacy in Prompting Keratinocytes Healing. Molecules 2020, 25, 431.

Molecules (Basel, Switzerland)·2026

[Expression of Concern] Ginsenoside Rg1 protects against H2O2‑induced neuronal damage due to inhibition of the NLRP1 inflammasome signalling pathway in hippocampal neurons in vitro.

International journal of molecular medicine·2026

Development of an MSPE-UHPLC-MS/MS method for bisphenols and alkylphenols in personal care products: a pilot study and preliminary safety assessment in China.

Analytical methods : advancing methods and applications·2026

Efficacy of Cannabinoids in Improving Nutritional Outcomes in Chemotherapy Patients: A Scoping Review.

Cureus·2026

Related Experiment Videos

Community-based therapeutic drug monitoring. Useful development or unnecessary distraction?

Related Concept Videos

Central pseudorapidity gaps in events with a leading antiproton at the fermilab tevatron pp collider.

Search for associated production of Upsilon and vector boson in pp collisions at sqrt[s]=1.8 TeV.

Search for the supersymmetric partner of the top quark in dilepton events from pp collisions at square root of s=1.8 TeV.

Search for long-lived charged massive particles in pp collisions at square root s = 1.8 TeV.

Comparison of modular and non-modular xylanases as carrier proteins for the efficient secretion of heterologous proteins from Penicillium funiculosum.

Search for a W' boson decaying to a top and bottom quark pair in 1.8 TeV pp collisions.

Clinical Pharmacokinetics and Disposition of Imrecoxib.

Towards Model-Informed Precision Dosing of High-Dose Rifampicin: A Parsimonious Population Pharmacokinetic Model Capturing Saturation and Autoinduction in Tanzanian and South African Patients with Tuberculosis.

From Clinical Trials to Real-World Patients: Population Pharmacokinetics and Precision Dosing Simulations of Lorlatinib.

Clinical Pharmacokinetics and Pharmacodynamics of Marstacimab, an Anti-tissue Factor Pathway Inhibitor Monoclonal Antibody, in Adolescent and Adult Participants with Hemophilia.

Target Attainment and Clinical and Biochemical Parameters Associated with the Pharmacokinetics of 12 Tyrosine Kinase Inhibitors.

A First-in-Human Study of Ulacamten, a Novel Cardiac Myosin Inhibitor for HFpEF.

Chelidonium majus L. alkaloid extract encapsulated in human serum albumin nanoparticles induces mitochondria-mediated apoptosis in HeLa cell line.

Reduced severe infection risk with avacopan in ANCA-associated vasculitis: a multicentre REVEAL cohort with time-varying exposure modelling.

RETRACTED: D'Agostino et al. Molecular Mechanisms at the Basis of Pharmaceutical Grade Triticum vulgare Extract Efficacy in Prompting Keratinocytes Healing. Molecules 2020, 25, 431.

[Expression of Concern] Ginsenoside Rg1 protects against H2O2‑induced neuronal damage due to inhibition of the NLRP1 inflammasome signalling pathway in hippocampal neurons in vitro.

Development of an MSPE-UHPLC-MS/MS method for bisphenols and alkylphenols in personal care products: a pilot study and preliminary safety assessment in China.

Efficacy of Cannabinoids in Improving Nutritional Outcomes in Chemotherapy Patients: A Scoping Review.

Related Experiment Videos

Community-based therapeutic drug monitoring. Useful development or unnecessary distraction?

Related Concept Videos

Related Articles